Print Page  Close Window

Investor Relations
Corporate Profile

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Allscripts is one of the largest public companies focused exclusively on healthcare information technology globally.  Allscripts offers healthcare providers, payers and life sciences companies globally a complete portfolio of clinical, financial, population health management, transaction and managed IT services and other solutions.  As of December 31, 2015, we had approximately 6,900 employees worldwide.   For 2015, revenue was $1.4 billion.  We operate in 12 countries including Australia, Canada, India Israel and the United Kingdom.

Our industry leading client base of 180,000 physicians across approximately 45,000 ambulatory facilities, 2,500 hospitals and 17,000 post-acute organizations.

We invite investors to learn more about Allscripts and the impact we have on health care around the globe - To learn more, visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.  Or please contact Seth R. Frank, Vice President of Investor Relations at

Recent NewsRSS Feeds | More >>
06/27/16Allscripts reinvigorating its EPSi™ business to accelerate innovation, drive client success
Expanded vision responds to value based care with aggressive solution roadmap CHICAGO, June 27, 2016 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) has implemented an aggressive strategy to drive innovation and client success through the EPSi solution, its flagship budgeting, cost accounting and financial decision support platform. The company will accelerate development with new executive leadership and a future-focused roadmap to meet rapidly changing market needs. “Having been a chief fin... 
Printer Friendly Version
06/09/16Allscripts earns top spot in 2016 ambulatory EHR user satisfaction poll from Black Book Rankings(TM)
Allscripts electronic health records (EHRs) rank highest for overall satisfaction and client loyalty among large group practices CHICAGO, June 09, 2016 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) earned top scores in multiple categories and criteria for its ambulatory EHRs, including Allscripts Professional EHRTM, Allscripts TouchWorks® EHR and Allscripts SunriseTM Ambulatory Care, from research company Black Book RankingsTM (Black Book). The firm collected results for operational excellence... 
Printer Friendly Version
05/05/16Allscripts announces first quarter 2016 results
Record first quarter bookings of $252 million Adjusted EBITDA and free cash flow grow in excess of 20 percent year-over-year Non-GAAP EPS of $0.13 and GAAP EPS of $0.01 CHICAGO, May 05, 2016 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2016. First Quarter Business Highlights             Allscripts announced a transaction in March to create a joint venture that merges Nets... 
Printer Friendly Version
04/19/16Allscripts Closes Netsmart Technologies Transaction
CHICAGO, April 19, 2016 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ:MDRX), a leader in healthcare IT solutions, today announced that it has completed the previously announced joint venture that merges the Allscripts Homecare™ business with Netsmart Technologies, Inc. (“Netsmart”).  This transaction establishes Netsmart as the largest human services and post-acute technology provider in healthcare. The joint venture will focus on enhancing human services, post-acute care and ... 
Printer Friendly Version
EventsMore >>
05/05/16 4:30 p.m. ET
Q1 2016 Allscripts Healthcare Solutions, Inc. Earnings Conference Call
03/16/16 8:30 a.m. ET
Allscripts Healthcare Solutions, Inc. at Barclays Global Healthcare Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources